These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14119861)

  • 41. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. II. THE KINETICS OF ACTIVATION.
    WERKHEISER WC; MARKUS G
    J Biol Chem; 1964 Aug; 239():2644-50. PubMed ID: 14235548
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of clotting as the result of plasminogen activation by streptokinase. 2. Analytical studies of the clotting mechanism.
    BELLER FK; GLAS P
    Thromb Diath Haemorrh; 1960 Jun; 4():520-33. PubMed ID: 13798543
    [No Abstract]   [Full Text] [Related]  

  • 43. Stability of the activator of bovine plasminogen.
    ABLONDI FB; HAGAN JJ
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):414-7. PubMed ID: 13389477
    [No Abstract]   [Full Text] [Related]  

  • 44. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. II. COMPARISON OF PEPTIDE LIBERATION DURING INCUBATION WITH AND WITHOUT STREPTOKINASE.
    RIFE U; SHULMAN S
    Biochim Biophys Acta; 1964 May; 86():328-38. PubMed ID: 14171007
    [No Abstract]   [Full Text] [Related]  

  • 45. Antagonistic action of urokinase to bradykinin- and plasminogen-induced capillary permeability.
    COPLEY AL; TSULUCA V
    Nature; 1963 Jan; 197():294-5. PubMed ID: 14022898
    [No Abstract]   [Full Text] [Related]  

  • 46. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS].
    SANTOSTORIBIO F
    Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889
    [No Abstract]   [Full Text] [Related]  

  • 47. [APPLICATION OF PROTEASE TO SURGERY AND ITS EVALUATION].
    ISHIKAWA K; SUGAWARA K
    Sogo Rinsho; 1964 May; 13():817-22. PubMed ID: 14156122
    [No Abstract]   [Full Text] [Related]  

  • 48. THE EFFECT OF INDUCED FIBRINOLYSIS AND VARIOUS SUBSTANCES ON THE MAST CELLS IN THE PERITONEAL FLUID AND MESENTERY OF THE RAT.
    CRONBERG S; NILSSON IM
    Acta Pathol Microbiol Scand; 1964; 60():156-63. PubMed ID: 14121975
    [No Abstract]   [Full Text] [Related]  

  • 49. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. I. THE RELEASE OF PEPTIDE FRAGMENTS.
    SHULMAN S; RIFE U
    Biochim Biophys Acta; 1964 May; 86():317-27. PubMed ID: 14171006
    [No Abstract]   [Full Text] [Related]  

  • 50. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 51. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR.
    GUTMAN M; RIMON A
    Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on the inactivation of streptokinase-activated plasmin].
    BELLER FK; REINHARDT U
    Blut; 1958 Dec; 4(6-7):367-72. PubMed ID: 13618385
    [No Abstract]   [Full Text] [Related]  

  • 53. PURIFICATION OF STREPTOKINASE AND HUMAN PLASMIN AND THEIR INTERACTION. REP 578.
    BLATT WF; SEGAL H; GRAY JL
    Rep US Army Med Res Lab; 1963 Jun; ():1-17. PubMed ID: 14131246
    [No Abstract]   [Full Text] [Related]  

  • 54. [THROMBOLYTIC THERAPY].
    ISIDORI A
    Rass Fisiopatol Clin Ter; 1964; 36():219-27. PubMed ID: 14174161
    [No Abstract]   [Full Text] [Related]  

  • 55. [ENZYME THERAPY IN SURGERY].
    ISHIKAWA K; SUGAWARA K; ONO H; KONO N; TOYAMA J
    Chiryo; 1964 Jul; 46():1217-23. PubMed ID: 14176350
    [No Abstract]   [Full Text] [Related]  

  • 56. Muller's phenomenon and its relationship to plasminogen activation and to blood constituents producing opacity in an agar gel.
    HUTCHISON JG
    J Pathol Bacteriol; 1962 Oct; 84():289-306. PubMed ID: 13955937
    [No Abstract]   [Full Text] [Related]  

  • 57. USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY.
    RITZ ND; RUBIN H
    J Lab Clin Med; 1964 Feb; 63():344-54. PubMed ID: 14125123
    [No Abstract]   [Full Text] [Related]  

  • 58. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 59. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 60. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME.
    MARKUS G; WERKHEISER WC
    J Biol Chem; 1964 Aug; 239():2637-43. PubMed ID: 14235547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.